Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oncocyte Corp 15 CUSHING IRVINE CA 92618 USA

www.oncocyte.com Employees: 46 P: 949-409-7600

Description:

OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 46,296
Enterprise Value, $K 36,866
Shares Outstanding, K 16,835
Annual Sales, $ 1,500 K
Annual Net Income, $ -27,780 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -13,490 K
EBIT, $ -43,600 K
EBITDA, $ -41,920 K
60-Month Beta 1.00
% of Insider Shareholders 1.58%
% of Institutional Shareholders 55.35%
Float, K 16,569
% Float 98.42%
Short Volume Ratio 0.70

Growth:

1-Year Return -33.08%
3-Year Return -94.29%
5-Year Return -92.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 47.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.98 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -2.47
EPS Growth vs. Prev Qtr -172.22%
EPS Growth vs. Prev Year -71.93%
Annual Dividend Yield 0.00%
Dividend Payable Date 01/30/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/25/23

OCX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -269.32%
Return-on-Assets % -59.71%
Profit Margin % -1,852.00%
Debt/Equity 0.00
Price/Sales 28.56
Price/Cash Flow N/A
Price/Book 4.42
Book Value/Share 0.58
Interest Coverage -496.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar